Chronic myelogenous leukemia

Susan O'Brien, Camille N. Abboud, Mojtaba Akhtari, Jessica Altman, Ellin Berman, Daniel J. DeAngelo, Steven Devine, Amir T. Fathi, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Javier Pinilla-Ibarz, Jerald P. Radich, Vishnu V.B. Reddy, Neil P. Shah, Paul J. Shami, B. Douglas Smith, David S. Snyder, Meir Wetzler, Furhan Yunus

Research output: Contribution to journalReview article

19 Scopus citations
Original languageEnglish (US)
Pages (from-to)64-110
Number of pages47
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Keywords

  • BCR-ABL
  • Chronic myelogenous leukemia
  • Dasatinib
  • Imatinib
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • Nilotinib
  • Stem cell transplant
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Oncology

Cite this

O'Brien, S., Abboud, C. N., Akhtari, M., Altman, J., Berman, E., DeAngelo, D. J., Devine, S., Fathi, A. T., Gotlib, J., Jagasia, M., Moore, J. O., Pinilla-Ibarz, J., Radich, J. P., Reddy, V. V. B., Shah, N. P., Shami, P. J., Smith, B. D., Snyder, D. S., Wetzler, M., & Yunus, F. (2012). Chronic myelogenous leukemia. JNCCN Journal of the National Comprehensive Cancer Network, 10(1), 64-110. https://doi.org/10.6004/jnccn.2012.0009